Ranbaxy shares fall after settlement with Pfizer
June 19th, 2008 - 9:44 pm ICT by IANS
-
Mumbai, June 19 (IANS) The share price of India’s leading drugmaker Ranbaxy Laboratories fell by nearly eight percent following the settlement with Pfizer on a patent dispute. The stock ended down 7.68 percent at the Bombay Stock Exchange at Rs.598.20 after touching a low of Rs.548.10 and a high of Rs.613.70.
On Wednesday, Pfizer said Ranbaxy can start selling a US generic form of its cholesterol drug Lipitor by late 2011.
Related Stories
- Ranbaxy sales may double by 2011 on Pfizer settlement - Jul 29, 2008
- Ranbaxy shares dip as US blocks import of its 30 drugs (Lead) - Sep 17, 2008
- Pfizer revises open offer for Indian arm - Jun 25, 2009
- Pfizer offers free prescription drugs to people who have lost their jobs - May 15, 2009
- Ranbaxy scrip plummets 17 percent as investors panic - Feb 26, 2009
- Ranbaxy gets USFDAs permission to manufacture cardiovascular drugs - Mar 09, 2009
- Ranbaxy posts Rs.6.8 bn losses in fourth quarter - Jan 22, 2009
- Daiichi, Ranbaxy to cooperate with US drug regulator as Indian firm faces charge (Lead) - Feb 26, 2009
- Equity markets go down after volatile day (Roundup) - Jun 18, 2008
- Ranbaxy, Daiichi Sankyo will dominate Japanese market: Malvinder - Jun 19, 2008
Categories
- Business
Posted in Business, |
